Matalliotakis et al., 2002 - Google Patents
Pulmonary endometriosis in a patient with unicornuate uterus and noncommunicating rudimentary hornMatalliotakis et al., 2002
View HTML- Document ID
- 6228457104651401995
- Author
- Matalliotakis I
- Goumenou A
- Koumantakis G
- Neonaki M
- Koumantakis E
- Arici A
- Publication year
- Publication venue
- Fertility and sterility
External Links
Snippet
Objective: To report a rare case of a patient with catamenial hemoptysis, secondary infertility, and endometriosis associated with a unicornuate uterus and noncommunicating rudimentary horn. Design: Case report. Setting: University hospital. Patient (s): A 29-year-old …
- 201000009273 endometriosis 0 title abstract description 39
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/42—Gynaecological or obstetrical instruments or methods
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Raziel et al. | Ovarian pregnancy—a 12-year experience of 19 cases in one institution | |
| Braun et al. | Is hysterosalpingography able to diagnose all uterine malformations correctly?: A retrospective study | |
| Amato et al. | Transient ovarian failure: a complication of uterine artery embolization | |
| Towbin et al. | Office hysteroscopy versus transvaginal ultrasonography in the evaluation of patients with excessive uterine bleeding | |
| Schankath et al. | Hysterosalpingography in the workup of female infertility: indications, technique and diagnostic findings | |
| Samal et al. | Cervical ectopic pregnancy | |
| Bonnamy et al. | Sonohysterography: a prospective survey of results and complications in 81 patients | |
| Sood et al. | Invasive cervical cancer complicating pregnancy: how to manage the dilemma | |
| Kayem et al. | Fertility after conservative treatment of placenta accreta | |
| Wallach et al. | Early miscarriage and fetal malformations after induction of ovulation (by clomiphene citrate and/or human menotropins), in vitro fertilization, and gamete intrafallopian transfer | |
| Matorras et al. | Endometriosis and spontaneous abortion rate: a cohort study in infertile women | |
| Chen et al. | Heterotopic cervical pregnancy successfully treated with transvaginal ultrasound-guided aspiration and cervical-stay sutures | |
| Kim et al. | Sonohysterographic screening before in vitro fertilization | |
| Dechaud et al. | Prospective evaluation of falloposcopy. | |
| Matalliotakis et al. | Pulmonary endometriosis in a patient with unicornuate uterus and noncommunicating rudimentary horn | |
| Cumming et al. | Combined laparoscopy and hysteroscopy in the investigation of the ovulatory infertile female | |
| Long et al. | Reoperation and pain-related outcomes after hysterectomy for endometriosis by oophorectomy status | |
| Lou et al. | Reproductive outcomes of cesarean scar pregnancies pretreated with methotrexate and uterine artery embolization prior to curettage | |
| Matsui et al. | Risk of abnormal pregnancy completing chemotherapy for gestational trophoblastic tumor | |
| Israel et al. | Diagnostic laparoscopy: a prognostic aid in the surgical management of infertility | |
| Wagenaar et al. | Hysteroscopic morcellation vs. curettage for removal of retained products of conception: a multicenter randomized controlled trial | |
| Radpour et al. | Consecutive cervical pregnancies | |
| Barmat et al. | Pregnancy: CASE REPORT Twin gestation occupying separate horns of a bicornuate uterus after in-vitro fertilization and embryo transfer | |
| Tajima et al. | Cervical pessary plus vaginal progesterone versus long‐term tocolysis for the prevention of preterm birth: An observational retrospective study | |
| Tiwari et al. | A comparative study to evaluate diagnostic accuracy and correlation between saline infusion sonography, hysterosalpingography and diagnostic hysterolaparoscopy in infertility |